Tag: report
Gilead won a valuable FDA voucher with its Veklury approval, but...
Gilead Sciences has the most successful COVID-19 drug so far in Veklury, an antiviral also known as remdesivir that was originally developed through research programs into hepatitis C and respiratory syncytial virus....
Merck, Pfizer pneumonia vaccines running low in EU as researchers fight...
As COVID-19 continues to rage worldwide, health authorities worry that a perfect storm of the novel coronavirus, pneumonia and seasonal flu could overtake hospital...
Pharma and healthcare digital advertising jumps during pandemic: report
As advertising increasingly moves online, so has pharma and healthcare's share. This year the industry is expected to spend more than $9.5 billion on digital media,...
AstraZeneca puts a time limit on its COVID-19 ‘no-profit’ pledge: report
As more than a half-dozen pharma companies race to develop vaccines to fight COVID-19, AstraZeneca has stood out for its pledge that it won’t...
Is the massive HHS pandemic ad campaign falling apart? Celeb refusals...
The massive HHS ad campaign to allay pandemic fears may be unraveling.
First, there's pushback from agency employees who see the $300 million effort as politically...
HHS bids out massive $250M ad campaign to put hopeful spin...
The Department of Health and Human Services plans to spend $250 million in media communications to “defeat despair and inspire hope” around the coronavirus...
CMS to penalize hospitals, labs that don’t report Covid-19 data
A close-up view of a swab used by medical workers tend to administer the coronavirus test at the drive-in center at ProHealth Care on...
Report: Hospital margins down 96% since the start of 2020
Even as hospitals continued to recover in July, operating margins for 2020 are still down 96% compared with last year, according to a report...
Lupin shuts down Indian plant after 18 workers test positive for...
India's pharmaceutical manufacturing is no stranger to the novel coronavirus after multiple waves of infections have temporarily shut down operations at a number of drugmakers'...
FiercePharmaPolitics—FDA official leaves ‘Warp Speed’ to preserve independent regulatory power: report
Welcome to the FiercePharma political roundup, where each Monday we’ll highlight developments in Washington, D.C., and elsewhere that could affect drug pricing and how drugmakers operate.
As researchers...
